[ad_1]
Spokesmen for the FDA and J&J did not immediately respond to requests for comment.
The Washington Post first reported on the FDA’s plans.
The importance: GBS is a rare disease in which the body’s immune system attacks nerve cells. About 3,000 to 6,000 people develop the syndrome each year in the United States; recover most completely, although paralysis can occur in more severe cases.
GBS has been associated as a rare side effect with other vaccines, including a vaccine developed to combat the 1976 swine flu. Most adverse vaccine-related side effects are identified within two months of the vaccine. inoculation.
Most of the cases identified in the federal database were reported around two weeks after vaccination and were mostly seen in men aged 50 and older, the top CDC official said.
“The available data does not show a similar pattern with” the Pfizer and Moderna vaccines, said the official, which are made using different vaccine technology. These vaccines have been linked to rare cases of myocarditis, an inflammatory disease of the heart, mainly in men under the age of 30.
And after: The CDC’s vaccine advisory committee will discuss the matter at an “upcoming” meeting, the official said.
[ad_2]
Source link